Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy
M Lin,
HT Chiang,
SL Lin,
MS Chang,
BN Chiang,
HW Kuo,
and
MD Cheitlin
Department of Medicine, Veterans General Hospital-Kaohsiung, Taiwan, Republic of China.
OBJECTIVES. This study attempted to evaluate the long-term efficacy of enalapril versus hydralazine therapy on left ventricular volume, mass and function as well as on the renin-angiotensin system in chronic asymptomatic aortic regurgitation. BACKGROUND. We tested the hypothesis that early administration of a vasodilator drug might be able to reduce left ventricular dilation and mass expansion. Because the renin-angiotensin system may be activated in chronic aortic regurgitation, early enalapril therapy might be beneficial. METHODS. Between 1990 and 1993, 76 asymptomatic nonrheumatic patients with mild to severe chronic aortic regurgitation were enrolled in a randomized, double-blind trial comparing enalapril with hydralazine. All patients underwent serial noninvasive studies. Seventy patients completed the 12-month follow-up. RESULTS. At 1 year, patients receiving enalapril had a significant reduction in left ventricular end-diastolic and end-systolic volume indexes (124 +/- 15 vs. 108 +/- 17 ml/m2, p < 0.01; 50 +/- 12 vs. 40 +/- 14 ml/m2, p < 0.01, respectively) and mass index (131 +/- 16 vs. 113 +/- 19 g/m2, p < 0.01), whereas hydralazine therapy showed no significant changes. Both regimens not only had a significant reduction in left ventricular mean wall stress but also had a mild increase in exercise duration. Only enalapril therapy achieved a significant inhibition of the renin-angiotensin system, in contrast to hydralazine therapy. Moreover, the multiple r2 value from the analysis for end-diastolic volume index using the two variables of age and treatment drugs was 72.1% (p < 0.01). CONCLUSIONS. Both regimens decrease left ventricular mean wall stress. Enalapril therapy achieves significant left ventricular mass regression, left ventricular end-diastolic and end-systolic volume index reduction and renin-angiotensin system suppression. These findings suggest that early unloading enalapril therapy has the potential to favorably influence the natural history of chronic aortic regurgitation.
This article has been cited by other articles:
|
|
|
|
 
D. H. J. Elder, L. Wei, B. R. Szwejkowski, R. Libianto, A. Nadir, M. Pauriah, S. Rekhraj, T. K. Lim, J. George, A. Doney, et al.
The Impact of Renin-Angiotensin-Aldosterone System Blockade on Heart Failure Outcomes and Mortality in Patients Identified to Have Aortic Regurgitation: A Large Population Cohort Study
J. Am. Coll. Cardiol.,
November 8, 2011;
58(20):
2084 - 2091.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Gillam
Renin-Angiotensin System Blockade and Improved Clinical Outcomes in Chronic Aortic Regurgitation: Enough Ammunition to Revise Guidelines, or Do We Need a Randomized Controlled Trial?
J. Am. Coll. Cardiol.,
November 8, 2011;
58(20):
2092 - 2094.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Goel, P. P. Sengupta, F. Mookadam, H. P. Chaliki, B. K. Khandheria, and A. J. Tajik
Valvular regurgitation and stenosis: when is surgery required?
Heart Asia,
July 5, 2010;
1(1):
20 - 25.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Onishi, H. Kawai, K. Tatsumi, T. Kataoka, D. Sugiyama, H. Tanaka, Y. Okita, and K.-i. Hirata
Preoperative Systolic Strain Rate Predicts Postoperative Left Ventricular Dysfunction in Patients With Chronic Aortic Regurgitation
Circ Cardiovasc Imaging,
March 1, 2010;
3(2):
134 - 141.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation,
October 7, 2008;
118(15):
e523 - e661.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
September 23, 2008;
52(13):
e1 - e142.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Aboulhosn and J. S. Child
Left Ventricular Outflow Obstruction: Subaortic Stenosis, Bicuspid Aortic Valve, Supravalvar Aortic Stenosis, and Coarctation of the Aorta
Circulation,
November 28, 2006;
114(22):
2412 - 2422.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
e1 - e148.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol.,
August 1, 2006;
48(3):
598 - 675.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Bekeredjian and P. A. Grayburn
Valvular Heart Disease: Aortic Regurgitation
Circulation,
July 5, 2005;
112(1):
125 - 134.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Gaasch and E. C. Schick
Symptoms and left ventricular size and function in patients with chronic aortic regurgitation
J. Am. Coll. Cardiol.,
April 16, 2003;
41(8):
1325 - 1328.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Iung, C. Gohlke-Barwolf, P. Tornos, C. Tribouilloy, R. Hall, E. Butchart, and A. Vahanian
Recommendations on the management of the asymptomatic patient with valvular heart disease
Eur. Heart J.,
August 2, 2002;
23(16):
1253 - 1266.
[PDF]
|
|
|
|
|
|
|
N A Boon and P Bloomfield
The medical management of valvar heart disease
Heart,
April 1, 2002;
87(4):
395 - 400.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. St John Sutton
Predictors of long-term survival after valve replacement for chronic aortic regurgitation
Eur. Heart J.,
May 2, 2001;
22(10):
808 - 810.
[PDF]
|
|
|
|
|
|
|
S. T. Mast, J. G. Jollis, T. Ryan, K. J. Anstrom, and J. L. Crary
The Progression of Fenfluramine-Associated Valvular Heart Disease Assessed by Echocardiography
Ann Intern Med,
February 20, 2001;
134(4):
261 - 266.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Murakami, K. Mizushige, T. Noma, S. Kimura, Y. Abe, and H. Matsuo
Effects of Perindopril on Left Ventricular Remodeling and Aortic Regurgitation in Rats Assessed by Echocardiography
Angiology,
November 1, 2000;
51(11):
943 - 952.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Y. Mori, M. Nakazawa, H. Tomimatsu, and K. Momma
Long-term effect of angiotensin-converting enzyme inhibitor in volume overloaded heart during growth: a controlled pilot study
J. Am. Coll. Cardiol.,
July 1, 2000;
36(1):
270 - 275.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Devlin, J. Petrusha, K. Briesmiester, D. Montgomery, and M. R. Starling
Impact of Vascular Adaptation to Chronic Aortic Regurgitation on Left Ventricular Performance
Circulation,
March 2, 1999;
99(8):
1027 - 1033.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. C. Ashton Jr., D. J. Goldstein, D. D'Alessandro, A. D. Weinberg, D. Burkhoff, H. D. Rosskothen, G. M. Lemole, and M. C. Oz
DEVELOPMENT OF AN INTRALUMINAL DEVICE FOR THE TREATMENT OF AORTIC REGURGITATION: PROTOTYPE AND IN VITRO TESTING SYSTEM
J. Thorac. Cardiovasc. Surg.,
October 1, 1996;
112(4):
979 - 983.
[Abstract]
[Full Text]
|
|
|
|
